Cancer Archive — Page 30 of 69
-
March 10, 2021
Hockey Fights Cancer skates on to support Children’s Hospital
Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Lochlin Morris was named Champ of the Game at the Nashville Predators’ Hockey Fights Cancer game on Saturday, March 6. Beginning last season, each home game features a Children’s Hospital patient on the jumbotron as a Vanderbilt Health Champ of the Game. -
March 9, 2021
Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening
A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening. -
March 9, 2021
Markers for breast cancer progression
Vanderbilt researchers clarify how a microRNA associated with triple-negative breast cancer survival inhibits cancer progression, suggesting new treatment strategies. -
February 25, 2021
Gift in memory of Phran Galante boosts lung cancer research
A gift in memory of music industry executive and community philanthropist Phran Galante will support the work of Christine Lovly, MD, PhD, associate professor of Medicine and Ingram Professor of Cancer Research, to improve targeted therapies for lung cancer. -
February 22, 2021
MRI view of brain tumor prognosis
In patients with glioblastoma brain tumors, features detected on MRIs at diagnosis were associated with survival, Vanderbilt Medical Center investigators found. -
February 5, 2021
Convalescent plasma improved survival in COVID-19 patients with blood cancers
Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19). -
February 4, 2021
Potential biomarker for IBD severity, cancer risk identified
A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.